Dr. Liebman on the Use of Digital Surveillance in Melanoma

Video

In Partnership With:

Tracey Liebman, MD, discusses the use of digital surveillance in melanoma.

Tracey Liebman, MD, assistant professor, Ronald O. Perelman Department of Dermatology, NYU Langone School of Medicine, NYU Langone Health, discusses the use of digital surveillance in melanoma.

Digital surveillance has widespread utility in melanoma, says Liebman. For example, patients who have atypical nevi will undergo total body photography. These images can be monitored over time to help identify melanomas and reduce biopsies for normal moles.

Additionally, dermoscopic monitoring through sequential digital dermoscopy imaging can be used to determine whether a biopsy should be done. If there are any short-term changes in the dermoscopic close-up image, a biopsy should be performed, says Liebman; this can diagnose melanoma at a very early stage, Liebman concludes.

Related Videos
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center